Bookmarks
Long term follow-up of Azithromycin Therapy for Chronic Lung Disease of Prematurity. The AZTEC 2 (AZithromycin ThErapy for Chronic lung disease 2)
Safe People
Organisation name
Cardiff University
Organisation sector
Academic Institute
Applicant name(s)
Sailesh Kotecha
Funders/ Sponsors
NIHRHealth Technology Assessment (HTA)
Safe Projects
Project ID
nnrd6
Lay summary
The following research questions will be investigated: 1. Does azithromycin improve the long term respiratory outcomes of preterm-born children at 1 and 2 years of corrected age? 2. Does azithromycin improve the long term neurodevelopmental outcomes of preterm-born children at 1 and 2 years of corrected age?
Other approval committees
REC reference: 19/WA/0267
Safe Setting
Access type
Release